In August 2011, the HISO committee endorsed GS1 standards for automated product identification for all pharmaceutical products and supplies. This includes data carriers (barcodes), the Global Trade Item Number (GTIN) product identifier and other associated data definitions.
HISO later considered full endorsement of the GS1 standards for automated product identification for all medical devices and equipment following consultation with the relevant bodies and stakeholders, and with reference to decisions made in other significant jurisdictions such as the USA Food and Drug Administration and the European Union.
In June 2017, HISO completed this work and published a statement on medical device terminology and identification standards, which extends the endorsement of GS1 standards to medical devices and equipment.
GS1 is an international not-for-profit association with member organisations in over 100 countries, including New Zealand.
It is dedicated to the design and implementation of global standards and solutions to improve the efficiency and visibility of supply and demand chains globally and across sectors. The GS1 system of standards is the most widely used supply chain standards system in the world. So far more than 145 countries have adopted or are committed to adopting GS1 standards.
Global Trade Item Numbers (GTINs) are globally unique identifiers for manufactured products. Worldwide, about 90 percent of pharmaceuticals have a GTIN assigned. Many New Zealand manufacturers are already using GS1 compliant barcodes that carry a GTIN on their products.
Benefits of GS1 standards
- Enables improved and integrated processes with suppliers, distributors and customers
- Enables improved security and cost savings
- Enables the provision of reliable product information
- Provides a base for ensuring timely and accurate product recall and withdrawal.